Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied Therapeutics, Inc. - Common Stock (NQ:APLT)

0.4838 +0.0038 (+0.79%)
Streaming Delayed Price Updated: 10:03 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 205,780
Open 0.4800
Bid (Size) 0.4808 (8)
Ask (Size) 0.4868 (5)
Prev. Close 0.4800
Today's Range 0.4741 - 0.4900
52wk Range 0.2950 - 10.62
Shares Outstanding 114,846,271
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Applied Therapeutics Reports Q2 Loss
Via The Motley Fool
Applied Therapeutics Reports Second Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire

Performance

YTD
-46.1%
-46.1%
1 Month
+5.2%
+5.2%
3 Month
+11.1%
+11.1%
6 Month
-17.9%
-17.9%
1 Year
-91.8%
-91.8%

More News

Read More
These stocks are moving in today's after hours session
Via Chartmill
Top movers in Monday's after hours session
Via Chartmill
Applied Therapeutics Announces Key Leadership Appointments
From Applied Therapeutics
Via GlobeNewswire
Which stocks are experiencing notable movement on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top stock movements in today's session.
Via Chartmill
Gapping stocks in Monday's session
Via Chartmill
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports First Quarter 2025 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
From Applied Therapeutics
Via GlobeNewswire
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
From Applied Therapeutics
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
From Faruqi & Faruqi, LLP
Via Business Wire
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via TheNewswire.com
Topics Lawsuit
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
From The Rosen Law Firm PA
Via GlobeNewswire
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Lawsuit
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Lawsuit
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit

Frequently Asked Questions

Is Applied Therapeutics, Inc. - Common Stock publicly traded?
Yes, Applied Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Applied Therapeutics, Inc. - Common Stock trade on?
Applied Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Applied Therapeutics, Inc. - Common Stock?
The ticker symbol for Applied Therapeutics, Inc. - Common Stock is APLT on the Nasdaq Stock Market
What is the current price of Applied Therapeutics, Inc. - Common Stock?
The current price of Applied Therapeutics, Inc. - Common Stock is 0.4838
When was Applied Therapeutics, Inc. - Common Stock last traded?
The last trade of Applied Therapeutics, Inc. - Common Stock was at 08/20/25 10:03 AM ET
What is the market capitalization of Applied Therapeutics, Inc. - Common Stock?
The market capitalization of Applied Therapeutics, Inc. - Common Stock is 55.56M
How many shares of Applied Therapeutics, Inc. - Common Stock are outstanding?
Applied Therapeutics, Inc. - Common Stock has 56M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.